Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) — Cash Flow Reinvestment Rate
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥84.38 Million (capex CN¥84.38 Million ) from operating cash flow of CN¥446.51 Million. See Shijiazhuang Yiling Pharmaceutical Co Lt (002603) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shijiazhuang Yiling Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2008–2025)
Historical reinvestment intensity for Shijiazhuang Yiling Pharmaceutical Co Ltd across 17 annual periods. For the full cash flow conversion analysis, see Shijiazhuang Yiling Pharmaceutical Co Lt cash flow conversion.
Annual Cash Flow Reinvestment Rate for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Year-by-year capital reinvestment analysis for Shijiazhuang Yiling Pharmaceutical Co Ltd. See 002603 FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | CN¥1.00 Billion | CN¥1.78 Billion | CN¥245.62 Million | ▼ -84.3% |
| 2024 | 3.59x | CN¥2.19 Billion | CN¥611.01 Million | CN¥290.39 Million | ▼ -53.9% |
| 2023 | 7.78x | CN¥1.21 Billion | CN¥155.46 Million | CN¥310.83 Million | ▲ +1129.1% |
| 2022 | 0.63x | CN¥2.21 Billion | CN¥3.49 Billion | CN¥213.98 Million | ▼ -59.8% |
| 2021 | 1.58x | CN¥832.89 Million | CN¥528.69 Million | CN¥673.56 Million | ▲ +104.2% |
| 2020 | 0.77x | CN¥1.22 Billion | CN¥1.59 Billion | CN¥1.14 Billion | ▼ -94.2% |
| 2019 | 13.23x | CN¥912.02 Million | CN¥68.93 Million | CN¥454.43 Million | ▲ +147.9% |
| 2018 | 5.34x | CN¥386.34 Million | CN¥72.37 Million | CN¥187.23 Million | ▼ -36.7% |
| 2017 | 8.43x | CN¥966.75 Million | CN¥114.65 Million | CN¥180.35 Million | ▲ +516.0% |
| 2016 | 1.37x | CN¥877.97 Million | CN¥641.45 Million | CN¥373.03 Million | ▼ -78.6% |
| 2015 | 6.41x | CN¥845.18 Million | CN¥131.88 Million | CN¥478.43 Million | ▲ +50.8% |
| 2014 | 4.25x | CN¥450.19 Million | CN¥105.90 Million | CN¥450.19 Million | ▼ -42.6% |
| 2013 | 7.41x | CN¥409.83 Million | CN¥55.32 Million | CN¥409.83 Million | ▲ +75.0% |
| 2012 | 4.23x | CN¥296.89 Million | CN¥70.13 Million | CN¥296.89 Million | ▲ +345.2% |
| 2010 | 0.95x | CN¥285.02 Million | CN¥299.72 Million | CN¥285.02 Million | ▲ +43.7% |
| 2009 | 0.66x | CN¥210.57 Million | CN¥318.21 Million | CN¥210.57 Million | ▲ +8.4% |
| 2008 | 0.61x | CN¥128.27 Million | CN¥210.18 Million | CN¥128.27 Million | — |